Modulators of indoleamine 2,3-dioxygenase and methods of...

Details Modulators of indoleamine 2,3-dioxygenase and methods of... Modulators of indoleamine 2,3-dioxygenase and methods of...

2006-05-09

2011-10-11

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S227500, C514S236200, C514S254030, C514S256000, C514S314000, C514S326000, C514S364000, C514S340000, C544S138000, C544S058200, C544S333000, C544S367000, C546S167000, C546S210000, C546S269100, C546S269400

Reexamination Certificate

active

08034953

ABSTRACT:
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.

REFERENCES:
patent: 3553228 (1971-01-01), Freedman et al.
patent: 3948928 (1976-04-01), Nishimura et al.
patent: 4116974 (1978-09-01), Farge et al.
patent: 4323681 (1982-04-01), Wolf et al.
patent: 4699916 (1987-10-01), Sirrenberg et al.
patent: 5364864 (1994-11-01), Bigg et al.
patent: 5712294 (1998-01-01), Robert et al.
patent: 6482822 (2002-11-01), Bigg et al.
patent: 6780858 (2004-08-01), Li et al.
patent: 2004/0234623 (2004-11-01), Munn et al.
patent: 2006/0194802 (2006-08-01), Abdellaoui et al.
patent: 2006/0258719 (2006-11-01), Combs et al.
patent: 2007/0037752 (2007-02-01), Ansorge et al.
patent: 2007/0037785 (2007-02-01), Ansorge et al.
patent: 2007/0185165 (2007-08-01), Combs et al.
patent: 2007/0203140 (2007-08-01), Combs et al.
patent: 2007/0265257 (2007-11-01), Tanaka et al.
patent: 2008/0119491 (2008-05-01), Combs
patent: 2008/0125470 (2008-05-01), Combs et al.
patent: 2008/0146624 (2008-06-01), Combs et al.
patent: 2008/0182882 (2008-07-01), Combs et al.
patent: 2008/0214546 (2008-09-01), Combs et al.
patent: 2008/0214549 (2008-09-01), Shaw et al.
patent: 2009/0163545 (2009-06-01), Goldfarb
patent: 2009/0247586 (2009-10-01), Dunkel et al.
patent: 659457 (1965-08-01), None
patent: 659467 (1965-08-01), None
patent: 2500113 (2004-04-01), None
patent: 2040628 (1972-02-01), None
patent: 0352832 (1990-01-01), None
patent: 0516520 (1992-12-01), None
patent: 0536424 (1993-04-01), None
patent: 1038874 (2000-09-01), None
patent: 1188747 (2002-03-01), None
patent: 40 020710 (1965-09-01), None
patent: 4020710 (1965-09-01), None
patent: 58 208275 (1983-12-01), None
patent: 60 193968 (1985-10-01), None
patent: 62059283 (1987-03-01), None
patent: 02 006453 (1990-01-01), None
patent: 4297449 (1992-10-01), None
patent: 11171702 (1999-06-01), None
patent: 2001158785 (2001-06-01), None
patent: 2001158786 (2001-06-01), None
patent: 2230742 (2004-06-01), None
patent: 886740 (1981-12-01), None
patent: WO 97/14686 (1997-04-01), None
patent: WO 97/30047 (1997-08-01), None
patent: WO 97/42183 (1997-11-01), None
patent: WO 99/29310 (1999-06-01), None
patent: WO 99/62903 (1999-12-01), None
patent: WO 0052001 (2000-09-01), None
patent: WO01/51456 (2001-07-01), None
patent: WO0151456 (2001-07-01), None
patent: WO 02/00196 (2002-01-01), None
patent: WO 02/079200 (2002-10-01), None
patent: WO 02/102799 (2002-12-01), None
patent: WO03/045901 (2003-06-01), None
patent: WO 03045901 (2003-06-01), None
patent: WO 03/087347 (2003-10-01), None
patent: WO03/099805 (2003-12-01), None
patent: WO 2004029031 (2004-04-01), None
patent: WO 2004/094409 (2004-11-01), None
patent: WO 2005/019190 (2005-03-01), None
patent: WO 2005/037257 (2005-04-01), None
patent: WO2005/037779 (2005-04-01), None
patent: WO 2006/028284 (2006-03-01), None
patent: WO 2006/067532 (2006-06-01), None
patent: WO 2006/122150 (2006-11-01), None
patent: WO 2006/133417 (2006-12-01), None
patent: WO 2007068377 (2007-06-01), None
patent: WO2007/075598 (2007-07-01), None
patent: WO 2008/036642 (2008-03-01), None
patent: WO 2008/036643 (2008-03-01), None
patent: WO 2008/036652 (2008-03-01), None
patent: WO 2008/036653 (2008-03-01), None
patent: WO2008/058178 (2008-05-01), None
patent: WO 2008/073825 (2008-06-01), None
Yarovenko et al., Tetrahedron, 1990, 46(11), pp. 3941-3952.
An English translation of Andrianov et al., Zhurnal Organicheskoi Khimii, 1993, 29(5), pp. 1062-1066.
Scherle, P., “Characterization of Novel and Potent Inhibitors of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase (IDO) for Use as Cancer Therapy” presented on Mar. 5, 2009 at the Translational Research Cancer Center Consortium annual meeting in Philadelphia, PA.
A.R. Katritzky et al., “Synthesis of mono and symmetrical di-N-hydroxy- and N-aminoguanidines”. Journal of Ornanic Chemistry, 71(18):6753-8 (2006).
Peterson, A.C. et al., Evaluation of Functionalized Tryptophan Derivatives and related Compounds as Competitive Inhibitors of Indoleamine 2,3-DioxygenaseMed. Chem. Res.3, 531-544, 1994.
Takikawa et al., “Mechanism of Interferon-γ Action,”J. Biol. Chem.263(4):2041-8 (1988).
International Search Report for PCT/US06/17983, dated Aug. 2, 2006.
“Physicians' Desk Reference” (PDR, e.g., 1996 edition, Medical Economics Company, Montvale, NJ) Zh. Org. Chim. (1993), 29, 1062-1066.
Andrianov, B.G. et al., “Acid halides of r-aminofurazan-3-carbohydroxamic acids”, Latvian Institute of Organic Chemistry, 3:370-371 (1994).
Andrianov, V.G. et al., “4-aminofurazan-3-carboxamidoxime cyclization”, Khimiya Geterotsiklicheskikh Soedinenii (4):534-8 (1994)(Abstract only).
Andrianov, V.G. et al., “4-aminofurazan-3-hydroximic halides”, Institute of Organic Synthesis, 5:581-585 (1992).
Andrianov, V.G. et al., “Rearrangements of 5-trifluoromethyl-1,2,4-oxadiazoles by action of ammonia and amines”, UDC 547.793.2/3.04, 2406(88):707 (1988).
Andrianov, V.G. et al., “Ring formation reactions of 4-aminofurazan-3-carboxyamidoximes”, Chemistry of Heterocyclic Compounds, 30(4):470-474, 1994.
Andrianov, V.G. et al., “Synthesis of furazans by rearrangement of 3-acyl-1-oxa-2-azole oximes”, UDC 547.793.07(047) 2611(90):1199-1213 (1991).
Andrianov, V.G. et al., “Synthesis, structure, and rearrangement of 4-aminofurazan-3-carboxiamide oximes”, UDC 547.793.2, 29(5):877-880 (1994).
Andrianov, V.G. et al., “Synthesis, structure, and rearrangement of 4-aminofurazan-3-carboxylic acid amidoximes”, Zhurnal Organicheskoi Khimii 29(5):1062-6 (1993)(Abstract only).
Brown, et al., 1991, Adv. Exp. Med. Biol., 294: 425-35.
Daubener, et al., 1999, Adv. Exp. Med. Biol., 467: 517-24.
Friberg, M., Jennings, R., et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer: 101:151-155, 2002.
Grohmann, et al., 2003, Trends Immunol., 24: 242-8.
Ichikawa, T. et al., “A new synthesis of adenine and 4-aminoimidazole-5-carboxamide”, Central Research Laboratories, Ajinomoto Co., Inc., pp. 253-255 (1965).
J. Exp. Med. 196(4):447-57, Aug. 2002.
J. Heterocycl. Chem. (1965), 2, 253.
Ji, et al., J. Immunol, 2005, 175:1456-63.
Journal of Pharmaceutical Science, 66, 2 (1977).
Logan, et al., 2002, Immunology, 105: 478-87.
Medawar, 1953, Symp. Soc. Exp. Biol. 7: 320-38.
Meyer, Kevin G., “Improved synthesis of 3-aminofurazan-4-carboxylic acid”, Organic Preparations and Procedures INt. 36(4):361-363 (2004).
Mishnev, A.F. et al., “Crystal and molecular structure of isomers of the oxime of 3-aminofurazanoyl piperidine”, Translated from Zhurnal Strukturnoi Khimii, 32(3):45-48 (1991).
Muller et al., 2005, Nature Med., 11:312-9.
Munn, et al., 1998, Science 281: 1191-3.
Munn, et al., 2002, Science 297: 1867-70.
Munn, et al., 2004, J. Clin. Invest., 114(2): 280-90.
Poluektova LY, Munn DH, Persidsky Y, and Gendelman HE (2002). Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J. Immunol. 168(8):3941-9.
Portula et al., 2005, Blood, 106:2382-90.
Remington's Pharmaceutical Sciences, 17th ed., Mack Publishing Company, Easton, Pa., 1985, p. 1418.
Sambrook, J, Russel, D. Molecular Cloning: A laboratory Manual (3rd edition). Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY, USA. 2001.
Sono, M., Taniguchi, T., Watanabe, Y., and Hayaishi, O. (1980) J. Biol. Chem. 255, 1339-1345.
Synth. Commun. (1988), 18, 1427.
Taylor, et al., 1991, FASEB J., 5: 2516-22).
Uyttenhove et al., 2003, Nature Med., 9: 1269-74.
Uyttenhove, C., Pilotte, L., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9:1269-1274, 2003.
Von Heinrich Wieland et al, “Zur Konstitution der polymeren Knallsauren. Pericyanilsaure, Epicyanilsaure und Metacyanilsaure”, Eingelaufen am 25 pp. 54-79 (1929).
Von Hei

Affiliated with

Also associated with

Rating

Modulators of indoleamine 2,3-dioxygenase and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of indoleamine 2,3-dioxygenase and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of indoleamine 2,3-dioxygenase and methods of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4287583